NASDAQ:INM | Profit Breakdown | InMed Pharmaceuticals Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-09-30 to 2026-03-31
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-03-31-$2.79M-$2.97M
2025-12-31$820,188.00$184,194.00-$2.03M-$2.03M
2025-09-30$1.12M$403,159.00-$1.73M-$1.73M
2025-06-30$1.3M$576,654.00-$1.31M-$1.79M
2025-03-31$1.26M$175,625.00-$2.07M-$2.12M
2024-12-31$1.11M$460,894.00-$2.58M-$2.58M
2024-09-30$1.26M$493,413.00-$1.68M-$1.68M
2024-06-30$1.28M$466,071.00-$1.93M-$1.94M
2024-03-31$1.17M$289,458.00-$1.72M-$1.72M
2023-12-31$1.24M$324,142.00-$1.48M-$1.48M
2023-09-30$901,862.00$21,242.00-$2.54M-$2.54M-$2.54M
2023-06-30-$458,741.00$1.57M-$338,391.00-$336,591.00-$338,391.00
2023-03-31$1.03M$192,511.00-$2M-$2M-$2M
2022-12-31$469,783.00$131,163.00-$2.1M-$2.1M-$2.1M
2022-09-30$320,788.00-$491,018.00-$3.51M-$3.5M-$3.51M
2022-06-30$791,078.00$249,714.00-$7.87M-$7.87M-$7.87M
2022-03-31$309,585.00$182,277.00-$3.48M-$3.48M-$3.48M
2021-12-31$265,092.00$111,555.00-$4.28M-$4.28M-$4.28M
2021-09-30-$2.97M-$2.97M-$2.97M
2021-06-30$880,634.00-$3.26M-$3.26M
2021-03-31$437,309.00-$3.1M-$3.1M
2020-12-31$276,790.00-$2.24M-$2.24M
2020-09-30-$1.6M
2020-06-30-$1.62M
2020-03-31-$2.02M
2019-12-31-$2.49M
2019-09-30-$2.81M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-06-30$4.94M$1.71M-$8.16M-$8.16M
2024-06-30$4.6M$1.1M-$7.67M-$7.68M
2023-06-30$1.37M$1.4M-$7.95M-$7.93M-$7.95M
2022-06-30$1.37M$543,546.00-$18.6M-$18.6M-$18.6M
2021-06-30$1.9M-$10.2M-$10.2M
2020-06-30-$8.94M